Clinical Trial Update: Impact of Budesonide Irrigations on Patients With Chronic Rhinosinusitis and Impact on Sinus Surgery Rates [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial evaluating budesonide irrigations in chronic rhinosinusitis has been withdrawn (Phase 2/Phase 3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sinus Congestion
• Sinus Infection
• Sinusitis

Drugs mentioned

• Budesonide (BUDESONIDE)

Snippet

Sponsor: Kaiser Permanente | Conditions: Chronic Sinus Infection, Chronic Sinusitis | Phase 2, Phase 3 | Status: WITHDRAWN